First Cat-Specific Blood Pressure Drug Approved — and the FDA File Shows Why Catching It Late Costs Vision
On April 29, 2026 the FDA approved AMODIP (amlodipine besylate chewable tablets, Ceva) — the first cat-specific drug for systemic hypertension in cats. In the field study systolic pressure fell 28.2 mmHg on average by Day 28. But the same FDA file notes that cats whose vision was already severely lost at treatment start were less likely to regain it even after the retina reattached. Feline hypertension travels with kidney disease and is invisible at home. What to do now.

What Was Approved

midArticleCta.byCategory.news.title
midArticleCta.byCategory.news.description
Dipercaya oleh lebih dari 380.000 pemilik kucing di 50 negara
Feline Hypertension Travels With Kidney Disease — and Shows You Nothing at Home
The Real Story Is One Sentence in the FDA File
Cats that had severe fundic lesions and severely decreased or absent vision at the start of treatment were less likely to regain visual function, despite retinal reattachment and improvement in retinal hemorrhages.
What To Do Now: Start by Asking for the Measurement
Turn Invisible Change Into a Record — CatsMe
Bisakah Anda menjawab "sejak kapan ini terjadi?"
Saat dokter hewan bertanya, jangan sampai Anda bingung. CatsMe mencatat skor kesehatan harian secara otomatis yang bisa dibagikan hanya dengan satu ketukan.
FAQ

Siap bertindak saat Anda merasa ada yang tidak beres
Cukup satu foto: AI membaca rasa sakit dan kondisi kesehatan dari ekspresi kucing Anda. Periksa saat Anda mulai khawatir, dan bagikan catatannya ke dokter hewan.